[Role of erythropoietin in the oncology patient: critical review of the literature].
Mustacchi
Giorgio
G
Cattedra di Oncologia Medica, Università di Trieste.
D000747:Anemia, Hypochromic / Q000188:drug therapy* / Q000209:etiology*; D000970:Antineoplastic Agents / Q000009:adverse effects; D002986:Clinical Trials as Topic; D004921:Erythropoietin / Q000009:adverse effects / Q000627:therapeutic use*; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D009369:Neoplasms / Q000097:blood* / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy; D011878:Radiotherapy / Q000009:adverse effects; D015996:Survival Rate; D013923:Thromboembolism / Q000139:chemically induced
D000970:Antineoplastic Agents; D006454:Hemoglobins; D004921:Erythropoietin